Delivery Route Comparison: Studying intranasal versus subcutaneous administration for peptide bioavailability research
We dont have much data yet, but one study from late in 2025, which compared tirzepatide to both transdermal (through the skin) testosterone and placebo, made an argument worth considering: Authors La Vignera & colleagues argued that tirzepatide may be effective in improving both metabolic parameters, ED, and gonadal hormone levels in patients with obesity and metabolic hypogonadism, also known as low testosterone levels
FOXO4-DRI is a breakthrough "third-generation" senolytic peptide engineered to selectively eliminate senescent cells ("zombie cells") that accumulate with aging
Clinical use suggests limited potential for pharmacokinetic interactions, though pharmacodynamic interactions remain possible given BPC-157's effects on vascular tone, growth factor signaling, and inflammatory pathways
Setting realistic expectations and following up with a qualified physician can help ensure that the treatment aligns safely with personal goals
Each rat passed the walkway three times, and after successfully obtaining three sets of data, the parameters were merged for further analysis